Clinical features of the study participants including CD4 counts, ART use, cotrimoxazole prophylaxis, respiratory symptoms and previous pneumococcal disease did not show significant differences between PML and KBTH. This evidence concerns the gene CD4 and progressive multifocal leukoencephalopathy.